CD276 and head and neck squamous cell carcinoma: Similarly, in head and neck squamous cell carcinoma, B7-H3 has emerged as a promising prognostic biomarker and an indicator for predicting responses to immune checkpoint blockade, thus opening up new therapeutic possibilities.